BactPac™ Delivery Platform

SiVEC’s BactPac™ delivery platform is built on a highly and carefully engineered bacterial strain that provides a safe and complete solution for both production and delivery of nucleic acid, protein, and gene therapy cargo. 

How does BactPac™ work?

BactPac™ uses normal flora bacteria engineered to 1) produce therapeutic nucleic acids, proteins, and gene editors, 2) deliver these therapeutic payloads to targeted tissues, and 3) release the payload into the targeted cell.

SiVEC Biotechnologies holds expertise and intellectual property (IP) for BactPac™, a platform technology that can be applied to target a wide range of diseases in humans and animals. Efforts are focused on broadening our bacterial platform’s applications, with an emphasis on ensuring strong IP protection.